Soils, Land and Food, Alan Wild

Автор: Kimble John M.
Название: Cryosols / Permafrost-Affected Soils
ISBN: 3540207511 ISBN-13(EAN): 9783540207511
Издательство: Springer
Рейтинг:
Цена: 36570.00 р.
Наличие на складе: Есть у поставщика Поставка под заказ.

Описание: Monitoring Committees: Why and How–David L. DeMets, Curt D. Furberg, Lawrence M. Friedman .-Lessons Learned–David L. DeMets .- FDA Perspective–Susan S. Ellenberg and Jay P. Siegel.- Introduction–Lawrence M. Friedman .- Assessing Possible Late Treatment Effects Early- The Diabetic Retinopathy Study Experience–Fred Ederer .- Data and Safety Monitoring in the Beta-Blocker Heart Attack Trial- Early Experiences in Formal Monitoring Methods–Lawrence M. Friedman, David L. DeMets and Robert Hardy .- Data Monitoring for the Aspirin Component of the Physicians Health Study- Importance of Secondary Outcomes–David L. DeMets and Charles H. Hennekens .- Early Termination of the Stroke Prevention in Atrial Fibrillation I Trial- Protecting Participant Interests in the Face of Scientific Uncertainties and the Cruel Play of Chance–Robert G. Hart, Lesly A. Pearce, Ruth McBride and Richard A. Kronmal .- Early Termination of the Diabetes Control and Complications Trial – Methodologic Issues–John M Lachin, Patricia Cleary, Oscar Crofford, Saul Genuth, David Nathan, Charles Clark, Frederick Ferris, and Carolyn Sieberg for the DCCT Research Group .- Data Monitoring in the AIDS Clinical Trials Group Study #981- Conflicting Interim Results–Dianne Finkelstein .- Challenges in Monitoring the Breast Cancer Prevention Trial–Carol K. Redmond,Joseph P. Costantino andTheodore Colton .- Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure- Potentially High Risk Treatment in High Risk Patients–Jan Feyzi, Desmond Julian, John Wikstrand and Hans Wedel .- Stopping the Randomized Aldactone Evaluation Study Early for Efficacy–Janet Wittes, Jean-Pierre Boissel, Curt Furberg, Desmond Julian, Henri Kulbertus and Stuart Pocock .- Data Monitoring in the Heart Outcomes Prevention Evaluation and the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events Trials- Avoiding Important Information Loss–Janice Pogue, David Sackett, George Wyse and Salim Yusuf .- Data Monitoring in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity Program–Stuart Pocock, Duolao Wang,Lars Wilhelmsen andCharles Hennekens .- Intro–Curt D. Furberg .- Breaking New Ground - Data Monitoring in the Coronary Drug Project–Paul L. Canner .- Data Monitoring in the Cardiac Arrhythmia Suppression Trial – The Need to Be Prepared Early–David L. DeMets and Lawrence M. Friedman .- Data Monitoring in the Prospective Randomized Milrinone Survival Evaluation Trial- Dealing with an Agonizing Trend–Susan Anderson, Robert Cody, Milton Packer andRichard Schwarz .- Stopping the Carotene and Retinol Efficacy Trial - The Viewpoint of the Safety and Endpoint Monitoring Committee–Anthony B. Miller, Julie Buring and O. Dale Williams .- Monitoring a Clinical Trial with Waiver of Informed Consent: Diaspirin Cross-Linked Hemoglobin for Emergency Treatment of Post - Traumatic Shock–Roger L. Lewis and Norman Fost .- Challenges in Monitoring the Heart and Estrogen/progestin Replacement Study–Stephen B. Hulley,Deborah Grady, Eric Vittinghoff and O. Dale Williams .- Data Monitoring in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial- Early Termination of the Doxazosin Arm–Barry R. Davis and Jeffrey A. Cutler .- Data Monitoring in the Moxonidone Congestive Heart Failure Trial–Stuart Pocock, Lars Wilhelmsen, Kenneth Dickstein, Gary Francis and Janet Wittes .- Data Monitoring of a Placebo-controlled Trial of Daclizumab in Acute Graft-versus-Host Disease–David Zahrich, Stephanie J. Lee and David Harrington .- Introduction–David L. DeMets .- Clinical Trials of Herpes Simplex Encephalitis: The Role of the Data Monitoring Committee–Richard J. Whitley .- The Nocturnal Oxygen Therapy Trial Data Monitoring Experience – Problem with Reporting Lags–David L. DeMets, George W. Williams andByron W. Brown, Jr. .- The Cooperative North Scandinavian Enalapril Survival Study II Trial–Steven Snapinn and Curt D. Furberg .- Lessons from Warfarin Trials in Atrial Fibrillation- Missing the Window of Opportunity–Charles H. Tegeler and Curt D. Furberg .- Data Monitoring in the Clinical Programs for Clinical Research in AIDS: The Toxoplasmic Encephalitis Study–James D. Neaton, Deborah N. Wentworth and Mark A. Jacobson .- Data Monitoring in the Randomized Evaluation of Strategies for Left Ventricular Dysfunction Pilot Study: When Reasonable People Disagree–Janice Pogue and Salim Yusuf .- Data Monitoring in the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study:Hazards of Changing Primary Outcomes–Desmond Julian.- Controversies in the Early Reporting of a Clinical Trial in Early Breast Cancer–Stephen L. George and Mark R. Green .- Making Independence Work: Monitoring the Bevacizumab Colorectal Cancer Clinical Trial–Janet Wittes, Eric Holmgren, Heidi Christ-Schmidt and Alex Bajamonde726